Longaeva Partners »

Arcutis Biotherapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.0M 345k 26.22

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Rubric Capital Management
Polar Capital Holdings
State Street Corporation
Vanguard Capital Management
Jennison Associates
Morgan Stanley
D. E. Shaw & Co
UBS Group
Bank of America Corporation
Geode Capital Management
Vanguard Portfolio Management
OrbiMed Advisors

View all funds holding Arcutis Biotherapeutics